Aptinyx to Report Fourth Quarter and Full Year 2019 Financial Results on Monday, March 30, 2020
March 18 2020 - 3:01PM
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical
company developing transformative therapies for the treatment of
brain and nervous system disorders, today announced that the
company will host a conference call and live webcast on Monday,
March 30, 2020 at 5:00 p.m. ET to report fourth quarter and full
year 2019 financial results and discuss recent business highlights.
To access the live conference call, please dial 1-866-930-5579
(domestic) or 1-409-216-0606 (international) and refer to
conference ID 4280058. A live audio webcast of the event will be
available on the Investors & Media section of Aptinyx’s website
at https://ir.aptinyx.com. A replay of the webcast will be
archived on Aptinyx’s website for 30 days following the event.
About AptinyxAptinyx Inc. is a clinical-stage
biopharmaceutical company focused on the discovery, development,
and commercialization of proprietary synthetic small molecules for
the treatment of brain and nervous system disorders. Aptinyx has a
platform for discovery of novel compounds that work through a
unique mechanism to modulate—rather than block or
over-activate—NMDA receptors and enhance synaptic plasticity, the
foundation of neural cell communication. The company has three
product candidates in clinical development in central nervous
system indications, including chronic pain, post-traumatic stress
disorder, and cognitive impairment associated with Parkinson’s
disease. Aptinyx is also advancing additional compounds from its
proprietary discovery platform, which continues to generate a rich
and diverse pipeline of small-molecule NMDA receptor modulators
with the potential to treat an array of neurologic disorders. For
more information, visit www.aptinyx.com.
Investor & Media Contact:Nick SmithAptinyx
Inc.ir@aptinyx.com or corporate@aptinyx.com847-871-0377
Aptinyx (NASDAQ:APTX)
Historical Stock Chart
From Apr 2024 to May 2024
Aptinyx (NASDAQ:APTX)
Historical Stock Chart
From May 2023 to May 2024